MEDI 428-Development of prostaglandin D2 receptor antagonist based on a tetrahydropyridoindole scaffold

被引：0

作者：

Beaulieu, Christian ^{[1
]}

Guay, Daniel ^{[1
]}

Wang, Zhaoyin ^{[1
]}

Leblanc, Yves ^{[1
]}

Roy, Patrick ^{[1
]}

Dufresne, Claude ^{[1
]}

Zamboni, Robert ^{[1
]}

Berthelette, Carl ^{[1
]}

Day, Stephen

Tsou, Nancy N. ^{[2
]}

Denis, Danielle ^{[3
]}

Greig, Gillian ^{[3
]}

Mathieu, Marie-Claude ^{[3
]}

Vigneault, Erika ^{[3
]}

O'Neill, Gary ^{[3
]}

机构：

[1] Merck Frosst Canada Inc, Dept Med Chem, Dorval, PQ H9R 4P8, Canada

[2] Merck Res Labs, Rahway, NJ 07065 USA

[3] Merck Frosst Canada Inc, Dept Biochem, Dorval, PQ H9R 4P8, Canada

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2007年 / 234卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

428-MEDI

引用

页数：1

共 50 条

[21] Pharmacokinetics of Laropiprant, a Selective Prostaglandin D2 Receptor 1 Antagonist, in Patients With Moderate Hepatic Impairment
Wang, Ying-Hong
Liu, Fang
Luk, Julie Ann Mabalot
Nirula, Ajay
Johnson-Levonas, Amy O.
Lasseter, Kenneth C.
Marbury, Thomas C.
Lunde, N. Martin
Wagner, John A.
Lai, Eseng
JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (03): : 406 - 412
[22] Antagonists of the Prostaglandin D2 Receptor CRTH2
Pettipher, Roy
Hansel, Trevor T.
DRUG NEWS & PERSPECTIVES, 2008, 21 (06) : 317 - 322
[23] A novel antagonist of prostaglandin D2 blocks the locomotion of eosinophils and basophils
Royer, J. F.
Schratl, P.
Carrillo, J. J.
Jupp, R.
Barker, J.
Weyman-Jones, C.
Beri, R.
Sargent, C.
Schmidt, J. A.
Lang-Loidolt, D.
Heinemann, A.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2008, 38 (09) : 663 - 671
[24] Prostaglandin D2 receptor antagonists in early development as potential therapeutic options for asthma
Santus, Pierachille
Radovanovic, Dejan
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (09) : 1083 - 1092
[25] Effects of ONO-4053, a DP1 (prostaglandin D2 receptor) antagonist, on prostaglandin D2-induced nasal allergic reactions
Okada, Y.
Yamaguchi, S.
Matsunaga, Y.
Nambu, F.
ALLERGY, 2015, 70 : 186 - 186
[26] Optimization of a Novel D2 Dopamine Receptor Antagonist Scaffold Reveals Exceptionally Selective and Potent Lead Molecules
Day, Marilyn M.
Dulcey, Andres E.
Bayron, Diane
Stang, Christopher R. T.
Moritz, Amy E.
Doyle, Trevor
Javitch, Jonathan A.
Southall, Noel T.
Ferrer, Marc
Marugan, Juan J.
Sibley, David R.
Free, R. Benjamin
FASEB JOURNAL, 2017, 31
[27] Pharmacodynamics, Pharmacokinetics, and Safety of AM211: A Novel and Potent Antagonist of the Prostaglandin D2 Receptor Type 2
Bain, G.
King, C. D.
Brittain, J.
Hartung, J. P.
DeArmond, I.
Stearns, B.
Truong, Y. P.
Hutchinson, J. H.
Evans, J. F.
Holme, K.
JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (10): : 1482 - 1493
[28] The pharmacokinetics and disposition of MK-0524, a Prostaglandin D2 receptor 1 antagonist, in rats, dogs and monkeys
Chang, S. W.
Reddy, V.
Pereira, T.
Dean, B. J.
Xia, Y.-Q.
Seto, C.
Franklin, R. B.
Karanam, B. V.
XENOBIOTICA, 2007, 37 (05) : 514 - 533
[29] Identification of an indole series of prostaglandin D2 receptor antagonists
Sturino, CF
Lachance, N
Boyd, M
Berthelette, C
Labelle, M
Li, LH
Roy, B
Scheigetz, J
Tsou, N
Brideau, C
Cauchon, E
Carriere, MC
Denis, D
Greig, G
Kargman, S
Lamontagne, S
Mathieu, MC
Sawyer, N
Slipetz, D
O'Neill, G
Wang, ZY
Zamboni, R
Metters, KM
Young, RN
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (11) : 3043 - 3048
[30] Discovery of orally active prostaglandin D2 receptor antagonists
Torisu, K
Kobayashi, K
Iwahashi, M
Nakai, Y
Onoda, T
Nagase, T
Sugimoto, I
Okada, Y
Matsumoto, R
Nanbu, F
Ohuchida, S
Nakai, H
Toda, M
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (19) : 4891 - 4895

← 1 2 3 4 5 →